Published in Nat Biotechnol on May 27, 2012
Computational design of ligand-binding proteins with high affinity and selectivity. Nature (2013) 2.81
Deep mutational scanning: a new style of protein science. Nat Methods (2014) 2.05
How good is automated protein docking? Proteins (2013) 1.80
Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently. Chem Soc Rev (2015) 1.74
Analyses of the effects of all ubiquitin point mutants on yeast growth rate. J Mol Biol (2013) 1.59
Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA. Immunol Rev (2012) 1.44
A comprehensive, high-resolution map of a gene's fitness landscape. Mol Biol Evol (2014) 1.36
Integrative, dynamic structural biology at atomic resolution--it's about time. Nat Methods (2015) 1.36
Broadly neutralizing antibodies against influenza viruses. Antiviral Res (2013) 1.29
Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin. J Virol (2013) 1.22
BeAtMuSiC: Prediction of changes in protein-protein binding affinity on mutations. Nucleic Acids Res (2013) 1.21
Community-wide evaluation of methods for predicting the effect of mutations on protein-protein interactions. Proteins (2013) 1.20
A comparison of successful and failed protein interface designs highlights the challenges of designing buried hydrogen bonds. Protein Sci (2012) 1.17
Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. J Virol (2013) 1.12
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science (2016) 1.10
Latent effects of Hsp90 mutants revealed at reduced expression levels. PLoS Genet (2013) 1.07
Deep sequencing: becoming a critical tool in clinical virology. J Clin Virol (2014) 1.07
Measuring the activity of protein variants on a large scale using deep mutational scanning. Nat Protoc (2014) 1.07
Dissecting enzyme function with microfluidic-based deep mutational scanning. Proc Natl Acad Sci U S A (2015) 1.05
High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution. Sci Rep (2014) 1.03
Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol (2015) 1.02
Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat Commun (2014) 0.99
Computational design of a protein-based enzyme inhibitor. J Mol Biol (2013) 0.98
Construction of a rationally designed antibody platform for sequencing-assisted selection. Proc Natl Acad Sci U S A (2012) 0.95
Computational design of a pH-sensitive IgG binding protein. Proc Natl Acad Sci U S A (2013) 0.94
Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody. J Virol (2014) 0.93
Engineering allostery. Trends Genet (2014) 0.93
Structure-based redesign of proteins for minimal T-cell epitope content. J Comput Chem (2013) 0.92
Prediction of homoprotein and heteroprotein complexes by protein docking and template-based modeling: A CASP-CAPRI experiment. Proteins (2016) 0.90
Determining effects of non-synonymous SNPs on protein-protein interactions using supervised and semi-supervised learning. PLoS Comput Biol (2014) 0.88
Viewing protein fitness landscapes through a next-gen lens. Genetics (2014) 0.88
Forcefield_PTM: Ab Initio Charge and AMBER Forcefield Parameters for Frequently Occurring Post-Translational Modifications. J Chem Theory Comput (2013) 0.86
High-resolution sequence-function mapping of full-length proteins. PLoS One (2015) 0.86
SORTCERY-A High-Throughput Method to Affinity Rank Peptide Ligands. J Mol Biol (2014) 0.86
Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family. ACS Synth Biol (2014) 0.85
MutaBind estimates and interprets the effects of sequence variants on protein-protein interactions. Nucleic Acids Res (2016) 0.85
Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing. MAbs (2013) 0.85
Computational design and experimental verification of a symmetric protein homodimer. Proc Natl Acad Sci U S A (2015) 0.84
Rapid Fine Conformational Epitope Mapping Using Comprehensive Mutagenesis and Deep Sequencing. J Biol Chem (2015) 0.84
Current Approaches for Diagnosis of Influenza Virus Infections in Humans. Viruses (2016) 0.84
From deep sequencing to actual clones. Protein Eng Des Sel (2014) 0.83
Plasmid-based one-pot saturation mutagenesis. Nat Methods (2016) 0.83
Mutational scanning reveals the determinants of protein insertion and association energetics in the plasma membrane. Elife (2016) 0.81
Rapid construction of metabolite biosensors using domain-insertion profiling. Nat Commun (2016) 0.80
Massively parallel determination and modeling of endonuclease substrate specificity. Nucleic Acids Res (2014) 0.80
Predicting the Effect of Mutations on Protein-Protein Binding Interactions through Structure-Based Interface Profiles. PLoS Comput Biol (2015) 0.80
Automated Structure- and Sequence-Based Design of Proteins for High Bacterial Expression and Stability. Mol Cell (2016) 0.80
De novo design and experimental characterization of ultrashort self-associating peptides. PLoS Comput Biol (2014) 0.79
Strategies to control the binding mode of de novo designed protein interactions. Curr Opin Struct Biol (2013) 0.79
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response. PLoS Pathog (2016) 0.79
The genetic code constrains yet facilitates Darwinian evolution. Nucleic Acids Res (2013) 0.79
SwiftLib: rapid degenerate-codon-library optimization through dynamic programming. Nucleic Acids Res (2014) 0.78
A generalized framework for computational design and mutational scanning of T-cell receptor binding interfaces. Protein Eng Des Sel (2016) 0.78
Exploring the functional residues in a flavin-binding fluorescent protein using deep mutational scanning. PLoS One (2014) 0.78
In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation. MAbs (2014) 0.78
Increasing affinity of interferon-γ receptor 1 to interferon-γ by computer-aided design. Biomed Res Int (2013) 0.78
Rational Protein Engineering Guided by Deep Mutational Scanning. Int J Mol Sci (2015) 0.78
A "fuzzy"-logic language for encoding multiple physical traits in biomolecules. J Mol Biol (2014) 0.78
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling. Nature (2017) 0.77
High-throughput evaluation of synthetic metabolic pathways. Technology (Singap World Sci) (2015) 0.77
Using experimental evolution to probe molecular mechanisms of protein function. Protein Sci (2015) 0.77
Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies. PLoS One (2015) 0.77
Using the concept of transient complex for affinity predictions in CAPRI rounds 20-27 and beyond. Proteins (2013) 0.77
Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration. J Biol Chem (2015) 0.77
A Statistical Guide to the Design of Deep Mutational Scanning Experiments. Genetics (2016) 0.76
Deep sequencing methods for protein engineering and design. Curr Opin Struct Biol (2016) 0.76
Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex. J Biol Chem (2016) 0.76
Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes. PLoS Pathog (2014) 0.75
Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping. Sci Rep (2017) 0.75
Next-generation protein engineering targets influenza. Nat Biotechnol (2012) 0.75
Identifying problematic drugs based on the characteristics of their targets. Front Pharmacol (2015) 0.75
De novo assembly and next-generation sequencing to analyse full-length gene variants from codon-barcoded libraries. Nat Commun (2015) 0.75
Generating High-Accuracy Peptide-Binding Data in High Throughput with Yeast Surface Display and SORTCERY. Methods Mol Biol (2016) 0.75
Molecular Determinants of Mutant Phenotypes, Inferred from Saturation Mutagenesis Data. Mol Biol Evol (2016) 0.75
Sort-seq under the hood: implications of design choices on large-scale characterization of sequence-function relations. BMC Genomics (2016) 0.75
Proteinquakes in the evolution of influenza virus hemagglutinin (A/H1N1) under opposing migration and vaccination pressures. Biomed Res Int (2015) 0.75
The Generation and Exploitation of Protein Mutability Landscapes for Enzyme Engineering. Chembiochem (2016) 0.75
High-Throughput Ligand Discovery Reveals a Sitewise Gradient of Diversity in Broadly Evolved Hydrophilic Fibronectin Domains. PLoS One (2015) 0.75
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2009) 53.36
Protein production by auto-induction in high density shaking cultures. Protein Expr Purif (2005) 29.74
Areas, volumes, packing and protein structure. Annu Rev Biophys Bioeng (1977) 16.38
Satisfying hydrogen bonding potential in proteins. J Mol Biol (1994) 14.79
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13
Protein structure prediction using Rosetta. Methods Enzymol (2004) 12.05
Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 11.26
High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science (1989) 8.73
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science (2011) 7.92
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science (2011) 7.86
ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol (2011) 7.33
Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 7.29
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
Isolating and engineering human antibodies using yeast surface display. Nat Protoc (2006) 5.02
Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science (2011) 4.42
Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science (1990) 3.89
High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis. Nat Biotechnol (2009) 3.58
High-resolution mapping of protein sequence-function relationships. Nat Methods (2010) 3.47
Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. Nature (2006) 3.19
Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution. J Mol Biol (1987) 2.79
Role of conformational sampling in computing mutation-induced changes in protein structure and stability. Proteins (2010) 2.56
Rapid construction of empirical RNA fitness landscapes. Science (2010) 2.52
Experimental illumination of a fitness landscape. Proc Natl Acad Sci U S A (2011) 2.25
RosettaScripts: a scripting language interface to the Rosetta macromolecular modeling suite. PLoS One (2011) 2.21
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob Agents Chemother (2001) 1.89
Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PLoS One (2010) 1.86
Deep mutational scanning: assessing protein function on a massive scale. Trends Biotechnol (2011) 1.74
Learning generative models for protein fold families. Proteins (2011) 1.71
Comprehensive and quantitative mapping of energy landscapes for protein-protein interactions by rapid combinatorial scanning. J Biol Chem (2006) 1.59
An improved yeast transformation method for the generation of very large human antibody libraries. Protein Eng Des Sel (2010) 1.48
Fine epitope mapping of anti-epidermal growth factor receptor antibodies through random mutagenesis and yeast surface display. J Mol Biol (2004) 1.43
Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother (2009) 1.37
Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL. J Mol Biol (2010) 1.37
One- and two-body decomposable Poisson-Boltzmann methods for protein design calculations. Protein Sci (2005) 1.02
Action-at-a-distance interactions enhance protein binding affinity. Protein Sci (2005) 1.00
The fitness landscapes of cis-acting binding sites in different promoter and environmental contexts. PLoS Genet (2010) 0.98
Design of a novel globular protein fold with atomic-level accuracy. Science (2003) 13.06
Protein structure prediction using Rosetta. Methods Enzymol (2004) 12.05
Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 11.26
Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature (2011) 11.07
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
Predicting protein structures with a multiplayer online game. Nature (2010) 9.95
HIV vaccine design and the neutralizing antibody problem. Nat Immunol (2004) 9.48
Toward high-resolution de novo structure prediction for small proteins. Science (2005) 9.18
Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. J Mol Biol (2003) 8.35
Macromolecular modeling with rosetta. Annu Rev Biochem (2008) 8.32
Kemp elimination catalysts by computational enzyme design. Nature (2008) 8.19
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. J Virol (2002) 7.82
Evaluation of structural and evolutionary contributions to deleterious mutation prediction. J Mol Biol (2002) 7.79
Structure of a V3-containing HIV-1 gp120 core. Science (2005) 7.69
High-resolution structure prediction and the crystallographic phase problem. Nature (2007) 7.67
De novo computational design of retro-aldol enzymes. Science (2008) 7.62
How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 7.57
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A (2004) 7.55
Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res (2004) 7.39
ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol (2011) 7.33
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature (2011) 7.20
Consistent blind protein structure generation from NMR chemical shift data. Proc Natl Acad Sci U S A (2008) 6.76
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science (2003) 6.68
A simple physical model for binding energy hot spots in protein-protein complexes. Proc Natl Acad Sci U S A (2002) 6.18
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (2010) 6.10
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A (2002) 6.00
A highly conserved neutralizing epitope on group 2 influenza A viruses. Science (2011) 5.66
Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J Virol (2003) 5.59
Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science (2013) 5.53
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 5.51
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science (2011) 5.44
Crystal structure of a monomeric retroviral protease solved by protein folding game players. Nat Struct Mol Biol (2011) 5.02
Towards robust regional estimates of CO2 sources and sinks using atmospheric transport models. Nature (2002) 4.71
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
An orientation-dependent hydrogen bonding potential improves prediction of specificity and structure for proteins and protein-protein complexes. J Mol Biol (2003) 4.63
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science (2013) 4.61
Assigning function to yeast proteins by integration of technologies. Mol Cell (2003) 4.58
Ca2+ indicators based on computationally redesigned calmodulin-peptide pairs. Chem Biol (2006) 4.52
Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science (2011) 4.42
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science (2007) 4.35
Protein-protein docking with backbone flexibility. J Mol Biol (2007) 4.32
Computational design of an enzyme catalyst for a stereoselective bimolecular Diels-Alder reaction. Science (2010) 4.32
Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins (2009) 4.27
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity (2005) 4.26
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog (2013) 4.23
New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10
Computational redesign of endonuclease DNA binding and cleavage specificity. Nature (2006) 4.06
Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature (2010) 4.04
Protein production and purification. Nat Methods (2008) 3.97
Automated de novo prediction of native-like RNA tertiary structures. Proc Natl Acad Sci U S A (2007) 3.87
Algorithm discovery by protein folding game players. Proc Natl Acad Sci U S A (2011) 3.74
Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science (2005) 3.72
Computational redesign of protein-protein interaction specificity. Nat Struct Mol Biol (2004) 3.66
Modeling structurally variable regions in homologous proteins with rosetta. Proteins (2004) 3.64
Structure prediction for CASP8 with all-atom refinement using Rosetta. Proteins (2009) 3.64
ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility. Proteins (2006) 3.60
Antibody vs. HIV in a clash of evolutionary titans. Proc Natl Acad Sci U S A (2005) 3.57
Rational HIV immunogen design to target specific germline B cell receptors. Science (2013) 3.55
Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science (2012) 3.53
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature (2008) 3.47
High-resolution mapping of protein sequence-function relationships. Nat Methods (2010) 3.47
Highly conserved protective epitopes on influenza B viruses. Science (2012) 3.47
Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature (2006) 3.45
Exploration of uncharted regions of the protein universe. PLoS Biol (2009) 3.41
Computational alanine scanning of protein-protein interfaces. Sci STKE (2004) 3.41
Automated prediction of CASP-5 structures using the Robetta server. Proteins (2003) 3.41
New algorithms and an in silico benchmark for computational enzyme design. Protein Sci (2006) 3.40
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial. Clin Infect Dis (2009) 3.32
Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. Structure (2004) 3.31
A Blueprint for HIV Vaccine Discovery. Cell Host Microbe (2012) 3.27
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A (2010) 3.24
Inflammation in neurodegenerative diseases. Immunology (2010) 3.22
An engineered microbial platform for direct biofuel production from brown macroalgae. Science (2012) 3.20
A dynamic knockout reveals that conformational fluctuations influence the chemical step of enzyme catalysis. Science (2011) 3.19
Temporal and geographic patterns of Aedes aegypti (Diptera: Culicidae) production in Iquitos, Peru. J Med Entomol (2004) 3.15
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol (2005) 3.12
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol (2013) 3.11
A large scale test of computational protein design: folding and stability of nine completely redesigned globular proteins. J Mol Biol (2003) 3.08
Atomic accuracy in predicting and designing noncanonical RNA structure. Nat Methods (2010) 3.07
Crystal structure of a bacterial cocaine esterase. Nat Struct Biol (2002) 3.06
Progress in modeling of protein structures and interactions. Science (2005) 3.05
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A (2009) 3.01
Structure prediction for CASP7 targets using extensive all-atom refinement with Rosetta@home. Proteins (2007) 3.01
Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol (2008) 3.00
NMR structure determination for larger proteins using backbone-only data. Science (2010) 3.00
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc Natl Acad Sci U S A (2013) 2.96
Refinement of protein structures into low-resolution density maps using rosetta. J Mol Biol (2009) 2.94
The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci U S A (2006) 2.88
De novo prediction of three-dimensional structures for major protein families. J Mol Biol (2002) 2.88
RosettaLigand docking with full ligand and receptor flexibility. J Mol Biol (2008) 2.86
Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat Rev Microbiol (2006) 2.83
Voltage sensor conformations in the open and closed states in ROSETTA structural models of K(+) channels. Proc Natl Acad Sci U S A (2006) 2.81